Plain-English translation of NCT07145190 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Parkinson Disease research guide →This trial is following people with Parkinson's disease who are starting , a medication taken under the tongue to treat sudden 'off' episodes (times when symptoms suddenly get worse). The study is not testing whether the medication works — doctors are already prescribing it as part of normal care. Instead, researchers want to learn how patients and doctors find the right dose for each person in real-world medical practice, and how the medication is actually used over time.
Doctors need better information about how to help patients find the right dose of this medication and how to use it effectively in daily life. By watching how the treatment is used in regular clinical care, researchers can understand what dose-finding approaches work best for different patients.
You likely qualify if…
You likely don't qualify if…
When you start the medication, you'll have a baseline visit at your clinic to test how you respond to an initial 10 mg dose. If that dose doesn't work well enough, you'll find your best dose at home over the next few days or weeks, keeping a simple diary of how you're doing. Your doctor will check in with you (by phone or visit) to confirm you've found a dose that works. After that, you'll continue recording your daily use in a diary for at least 7 days and 10 doses. All of this happens during your regular medical care — no extra tests or procedures are required.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
Germany